https://www.selleckchem.com/pr....oducts/tacrine-hcl.h
109, 95% CI 0.054-0.222; P less then 0.001), and HER2-enriched subtype (OR = 0.298, 95% CI 0.156-0.567; P less then 0.001). No clear relationship was observed between patient prognosis and METTL14 expression. It appears that downregulated METTL14 expression in breast cancer is associated with tumor grade and molecular classification. Long-term clinical data on the success and complication rates of monolithic or minimally veneered zirconia implant-supported restorations are lacking. Hence, the purpose of this retrospective clinical s
Like
Comment
Share
